{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:14:30Z","timestamp":1787775270762,"version":"build-2784847793"},"reference-count":42,"publisher":"BMJ","issue":"12","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation Project of China","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1136\/bjophthalmol-2016-310044","type":"journal-article","created":{"date-parts":[[2017,10,7]],"date-time":"2017-10-07T00:40:22Z","timestamp":1507336822000},"page":"1731-1738","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":41,"title":["Treatment of experimental autoimmune uveoretinitis with intravitreal injection of infliximab encapsulated in liposomes"],"prefix":"10.1136","volume":"101","author":[{"given":"Rui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2016-310044-1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"key-10.1136\/bjophthalmol-2016-310044-2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/cei.12626","article-title":"Anti-tumour necrosis factor treatment increases circulating T helper type 17 cells similarly in different types of inflammatory arthritis","volume":"181","author":"Hull","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1517\/13543784.2016.1126247","article-title":"Anti-TNF-\u03b1 therapies for the treatment of Crohn\u2019s disease: the past, present and future","volume":"25","author":"Berns","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"key-10.1136\/bjophthalmol-2016-310044-4","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/rheumatology\/keu266","article-title":"Anti-TNF-\u03b1 therapy in patients with refractory uveitis due to Beh\u00e7et\u2019s disease: a 1-year follow-up study of 124 patients","volume":"53","author":"Calvo-R\u00edo","year":"2014","journal-title":"Rheumatology"},{"key":"key-10.1136\/bjophthalmol-2016-310044-5","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.semarthrit.2014.09.012","article-title":"Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review","volume":"44","author":"Lubrano","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"key-10.1136\/bjophthalmol-2016-310044-6","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bjophthalmol-2013-303935","article-title":"Immunomodulatory therapy with tumour necrosis factor \u03b1 inhibitors in children with antinuclear antibody-associated chronic anterior uveitis: long-term results","volume":"98","author":"Doycheva","year":"2014","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-7","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","article-title":"Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et\u2019s disease: a multicenter study","volume":"121","author":"Takeuchi","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-310044-8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2016-310044-9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.survophthal.2015.06.004","article-title":"Anti-tumor necrosis factor-\u03b1 therapy in uveitis","volume":"60","author":"Cordero-Coma","year":"2015","journal-title":"Surv Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-10","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","article-title":"Efficacy of anti-TNF alpha in severe and\/or refractory Beh\u00e7et\u2019s disease: Multicenter study of 124 patients","volume":"62","author":"Vallet","year":"2015","journal-title":"J Autoimmun"},{"key":"key-10.1136\/bjophthalmol-2016-310044-11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1167\/iovs.07-0932","article-title":"A pilot study on ocular safety of intravitreal infliximab in a rabbit model","volume":"49","author":"Giansanti","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-12","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1167\/iovs.15-19023","article-title":"Efficacy of intravitreal injections of triamcinolone acetonide in a rodent model of nonarteritic anterior ischemic optic neuropathy","volume":"57","author":"Huang","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1586\/17469899.2014.951331","article-title":"Update on the prevention and treatment of endophthalmitis","volume":"9","author":"Schwartz","year":"2014","journal-title":"Expert Rev Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-14","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bjophthalmol-2014-306423","article-title":"Long-term outcomes of intravitreal ranibizumab for neovascular age-related macular degeneration in a well defined region of the UK","volume":"100","author":"Buckle","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ajo.2012.03.035","article-title":"Intravitreal infliximab for sight-threatening relapsing uveitis in Beh\u00e7et disease: a pilot study in 15 patients","volume":"154","author":"Markomichelakis","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ajo.2016.02.028","article-title":"Postinjection endophthalmitis rates and characteristics following intravitreal bevacizumab, ranibizumab, and aflibercept","volume":"165","author":"Rayess","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-17","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1089\/jop.2012.0203","article-title":"Intravitreal tumor necrosis factor-alpha inhibitors for neovascular age-related macular degeneration suboptimally responsive to antivascular endothelial growth factor agents: a pilot study from the Pan American Collaborative Retina Study Group","volume":"29","author":"Wu","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2016-310044-18","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ejpb.2014.12.023","article-title":"Current nanotechnology approaches for the treatment and management of diabetic retinopathy","volume":"95","author":"Fangueiro","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"key-10.1136\/bjophthalmol-2016-310044-19","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/la051654u","article-title":"Preparation of liposomes using an improved supercritical reverse phase evaporation method","volume":"22","author":"Otake","year":"2006","journal-title":"Langmuir"},{"key":"key-10.1136\/bjophthalmol-2016-310044-20","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1167\/iovs.09-4373","article-title":"Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes","volume":"51","author":"Zhang","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-21","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1167\/iovs.08-3171","article-title":"Dual role of intravitreous infliximab in experimental choroidal neovascularization: effect on the expression of sulfated glycosaminoglycans","volume":"50","author":"Regatieri","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-22","doi-asserted-by":"crossref","first-page":"5328","DOI":"10.1167\/iovs.09-3569","article-title":"Intravitreal infliximab clearance in a rabbit model: different sampling methods and assay techniques","volume":"50","author":"Giansanti","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1006\/exer.1997.0379","article-title":"Characterization of a potent uveitopathogenic site derived from rat phosducin","volume":"65","author":"Abe","year":"1997","journal-title":"Exp Eye Res"},{"key":"key-10.1136\/bjophthalmol-2016-310044-24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0021-5155(02)00538-5","article-title":"Suppression of experimental autoimmune uveoretinitis by anti-alphabeta TCR monoclonal antibody","volume":"46","author":"Inoki","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2016-310044-25","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1167\/iovs.07-1173","article-title":"Neuroprotective effects of naloxone against light-induced photoreceptor degeneration through inhibiting retinal microglial activation","volume":"49","author":"Ni","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-26","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00006982-200603000-00001","article-title":"Testing intravitreal toxicity of bevacizumab (Avastin)","volume":"26","author":"Manzano","year":"2006","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-310044-27","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jconrel.2012.11.005","article-title":"Polymeric hydrogels for oral insulin delivery","volume":"165","author":"Chaturvedi","year":"2013","journal-title":"J Controlled Release"},{"key":"key-10.1136\/bjophthalmol-2016-310044-28","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1021\/acs.biomac.5b00458","article-title":"Biodegradable pH-sensitive poly(ethylene glycol) nanocarriers for allergen encapsulation and controlled release","volume":"16","author":"Pohlit","year":"2015","journal-title":"Biomacromolecules"},{"key":"key-10.1136\/bjophthalmol-2016-310044-29","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1126\/science.1095833","article-title":"Drug delivery systems: entering the mainstream","volume":"303","author":"Allen","year":"2004","journal-title":"Science"},{"key":"key-10.1136\/bjophthalmol-2016-310044-30","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1016\/j.xphs.2016.03.038","article-title":"Biotin-conjugated multilayer poly [D,L-lactide-co-glycolide]-Lecithin-Polyethylene glycol nanoparticles for targeted delivery of doxorubicin","volume":"105","author":"Dai","year":"2016","journal-title":"J Pharm Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2009.02.020","article-title":"Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye","volume":"136","author":"Hironaka","year":"2009","journal-title":"J Control Release"},{"key":"key-10.1136\/bjophthalmol-2016-310044-32","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1021\/acs.biomac.5b00336","article-title":"Synthesis and characterization of hybrid polymer\/lipid expansile nanoparticles: imparting surface functionality for targeting and stability","volume":"16","author":"Stolzoff","year":"2015","journal-title":"Biomacromolecules"},{"key":"key-10.1136\/bjophthalmol-2016-310044-33","first-page":"253","article-title":"Intravitreal delivery of oligonucleotides by sterically stabilized liposomes","volume":"43","author":"Bochot","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-34","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/IJN.S30725","article-title":"Liposomes and nanotechnology in drug development: focus on ocular targets","volume":"8","author":"Honda","year":"2013","journal-title":"Int J Nanomedicine"},{"key":"key-10.1136\/bjophthalmol-2016-310044-35","first-page":"1296","article-title":"Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein","volume":"27","author":"Gery","year":"1986","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2016-310044-36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/IAE.0b013e3181bcef3b","article-title":"Adverse events after intravitreal infliximab (Remicade)","volume":"30","author":"Giganti","year":"2010","journal-title":"Retina"},{"key":"key-10.1136\/bjophthalmol-2016-310044-37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02713683.2016.1227447","article-title":"Retinal toxicity of intravitreal granulocyte colony-stimulating factor in rabbit Eyes","volume":"42","author":"Falavarjani","year":"2017","journal-title":"Curr Eye Res"},{"key":"key-10.1136\/bjophthalmol-2016-310044-38","doi-asserted-by":"crossref","first-page":"621","DOI":"10.18553\/jmcp.2013.19.8.621","article-title":"Costs of tumor necrosis factor blockers per treated patient using real-world drug data in a managed care population","volume":"19","author":"Schabert","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"key-10.1136\/bjophthalmol-2016-310044-39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2015.02.012","article-title":"Enhanced glutathione PEGylated liposomal brain delivery of an anti-amyloid single domain antibody fragment in a mouse model for Alzheimer\u2019s disease","volume":"203","author":"Rotman","year":"2015","journal-title":"J Control Release"},{"key":"key-10.1136\/bjophthalmol-2016-310044-40","doi-asserted-by":"crossref","first-page":"120906061906007","DOI":"10.1089\/jop.2011.0199","article-title":"Long-term effects of intravitreal infliximab for treatment of sight-threatening chronic noninfectious uveitis","volume":"28","author":"Farvardin","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2016-310044-41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.carbpol.2015.12.014","article-title":"Layer-by-layer polysaccharide-coated liposomes for sustained delivery of epidermal growth factor","volume":"140","author":"Kaminski","year":"2016","journal-title":"Carbohydr Polym"},{"key":"key-10.1136\/bjophthalmol-2016-310044-42","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2011.04.005","article-title":"Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes)","volume":"153","author":"Smith","year":"2011","journal-title":"Journal of Controlled Release"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bjophthalmol-2016-310044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T02:27:27Z","timestamp":1659580047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2016-310044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2017,11,23]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/bjophthalmol-2016-310044"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2016-310044","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,6]]}}}